FindTrial
Sign In

New 1arge intergenic non-coding RNA (Linc-RNA) mutations in diffused gastric carcinoma

Long non-coding sequencing identify new 1arge intergenic non-coding RNA (Linc-RNA) mutations in in diffused gastric carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CDC-15007379
Enrollment
Unknown
Registered
2015-10-28
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

diffuse gastric cancer:Long non-coding sequencing identify

Sponsors

Shanghai Changhai Hospital,The Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient was operated in the Department of general surgery, Changhai Hospital of Shanghai and diagnosed as cases of diffuse type of gastric cancer by histopathology after the implementation of surgery; 2. No neoadjuvant chemotherapy was administered before surgery; 3 Clinical parameters for function of important organs lies in normal range, e.g., white blood cell >3.5*10^9/L; platelet >300*10^9/L; creatinine < normal limit of 1.25 times; 2.5 times the upper limit of the normal value of S and <13.0.

Exclusion criteria

Exclusion criteria: Patients with two or more tumors.

Design outcomes

Primary

MeasureTime frame
lincRNA;—

Countries

China

Contacts

Public ContactJianwei Bi
bijianwei@medmail.com.cn+86 021-31161593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026